Acadia Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.51B 46.61M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Incyte USD 3.67B 219.94M 2025-03
J&J USD 78.11B 6.62B 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Prothena USD 486.93M 47.44M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Acadia Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.